Focus Financial Network’s Vertex Pharmaceuticals VRTX Stock Holding History

Focus Financial Network’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$247K	Buy	498 +5	+1%	+$2.22K	0.01%	668
2026 Q1	$220K	Sell	493 -31	-6%	-$14.5K	0.01%	674
2025 Q4	$238K	Sell	524 -15	-3%	-$6.46K	0.01%	651
2025 Q3	$211K	Sell	539 -67	-11%	-$28K	0.01%	704
2025 Q2	$270K	Buy	606 +33	+6%	+$15.2K	0.01%	602
2025 Q1	$278K	Buy	573 +15	+3%	+$6.99K	0.01%	571
2024 Q4	$225K	Hold	558	–	–	0.01%	628
2024 Q3	$260K	Buy	558 +37	+7%	+$17.8K	0.01%	586
2024 Q2	$254K	Hold	521	–	–	0.01%	574
2024 Q1	$205K	Sell	521 -81	-13%	-$34.2K	0.01%	598
2023 Q4	$245K	Hold	602	–	–	0.01%	631
2023 Q3	$209K	Hold	602	–	–	0.01%	550
2023 Q2	$212K	Sell	602 -73	-11%	-$24.6K	0.01%	547
2023 Q1	$213K	Buy	+675	New	+$202K	0.01%	526

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Focus Financial Network's VRTX Position: Q2 2026 in Review

Focus Financial Network increased its Vertex Pharmaceuticals (VRTX) stake by 1% in Q2 2026, buying an estimated $2.22K and bringing the position to 498 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #668.

Focus Financial Network first reported a position in VRTX in Q1 2023 and has held it in 14 quarters since. The position peaked at $278K in Q1 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Focus Financial Network held 498 shares of Vertex Pharmaceuticals worth $247K as of Q2 2026.
Focus Financial Network bought 5 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.22K.
Vertex Pharmaceuticals made up 0.01% of Focus Financial Network's portfolio in Q2 2026, its #668 holding.
Focus Financial Network first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
Focus Financial Network's Vertex Pharmaceuticals position peaked at $278K in Q1 2025.
334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Focus Financial Network's 13F filing for Q2 2026, filed 9 Jul 2026.